Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001477
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
1999-11-03
Brief Title:
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
Status:
COMPLETED
Status Verified Date:
2000-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients are exposed to infectious agents regularly regardless of their immunologic status Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors skin test ie PPD or immunologic parameters A quantitative and specific method that is non-invasive such as quantitative PCR would be desirable to more precisely define those who would benefit from prophylaxis Similarly when patients develop disease and are being treated quantitative non-invasive techniques are needed to assess response to therapy This project is designed to develop and test quantitative tests using blood urine or sputum samples
Detailed Description:
Patients are exposed to infectious agents regularly regardless of their immunologic status Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors skin test ie PPD or immunologic parameters A quantitative and specific method that is non-invasive such as quantitative PCR would be desirable to more precisely define those who would benefit from prophylaxis Similarly when patients develop disease and are being treated quantitative non-invasive techniques are needed to assess response to therapy This project is designed to develop and test quantitative tests using blood urine or sputum samples
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 95-I-0176 | None | None | None |